...Dimitrios Poulikakos; Marek Malik; Debasish Banerjee Background: Depressed heart rate variability (HRV) reflects abnormal cardiac autonomic regulation and has been linked with increased cardiovascular risk and sudden cardiac death. High parathyroid hormone (PTH) levels have also been associated...

...). Previous studies showed raised parathyroid hormone (PTH) levels when aiming for serum ionized calcium [Ca i ] between 0.8 and 1.1 mmol/l. Our objective was to assess whether citrate-based CRRT with physiologic target systemic [Ca i ] between 1.12 and 1.20 mmol/l could maintain stable PTH levels. Methods...

...Kerry Cooper; Darryl Quarles; Yumi Kubo; Holly Tomlin; William Goodman Background/Aim: The relationship between changes in plasma parathyroid hormone (PTH) and serum phosphorus levels during treatment with cinacalcet was evaluated in hemodialysis patients with secondary hyperparathyroidism (SHPT...

... phosphate, adjusted calcium, parathyroid hormone, bicarbonate and total cholesterol. In addition longitudinal analyses were performed (2000–2010) to show changes in achievement of clinical performance measures over time. Results: Fiftysix percent of HD and 69% of PD patients achieved a phosphate within...

... parathyroid hormone (PTH, >190 pg/ml) and fibroblast growth factor (FGF)-23 levels (>3,000 RU/ml) is associated with the risk of VC progression (OR 5.8, 95% CI 1.7–19.8, p = 0.004). Calcitriol analogs (38%), cinacalcet (15%), dialysate calcium (mean 1.48 mmol/l), dialysis session time (4–8 h...

.... The biochemical variables studied were phosphate, adjusted calcium, parathyroid hormone, bicarbonate and total cholesterol. In addition longitudinal analyses were performed (2000–2009) to show changes in achievement of clinical performance measures over time. Results: Sixtyone percent of HD and 70% of PD patients...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. mineral bone disorders chronic kidney disease parathyroid hormone calcium phosphate phosphate binder Nephron Clin Pract 2011;118(suppl 1...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Biochemical marker Bone loss Hemodialysis Parathyroid hormone Radius...

...G. Jean; D. Lataillade; L. Genet; E. Legrand; F. Kuentz; X. Moreau-Gaudry; D. Fouque; on behalf of the ARNOS study investigators Introduction: A very low parathyroid hormone (PTH) level (VLPL) is associated with an increased risk of adynamic bone disease, vascular calcification, and mortality...

... intact parathyroid hormone (iPTH), Ca and P serum levels in patients with secondary hyperparathyroidism (SHPT). Methods: This Spanish, multicenter, observational, retrospective study collected data from SHPT dialysis patients 12 weeks before and up to 72 weeks after starting cinacalcet in clinical...

...Csaba P. Kovesdy; Miklos Z. Molnar; Maria E. Czira; Anna Rudas; Akos Ujszaszi; Eniko Sarvary; Csaba Ambrus; Miklos Szathmari; Adam Remport; Istvan Mucsi Background/Aims: Elevated parathyroid hormone (PTH) is used to diagnose high turnover bone disease in chronic kidney disease (CKD). The diagnostic...

...Sun Chul Kim; Hye Won Kim; Se Won Oh; Ha Na Yang; Myung-Gyu Kim; Sang-Kyung Jo; Won Yong Cho; Hyoung Kyu Kim Background: There is substantial evidence that low levels of serum intact parathyroid hormone (iPTH) are associated with vascular calcium deposition and subsequent increased cardiovascular...

... and 6 months after PEIT. Results: Serum intact parathyroid hormone (i-PTH) level showed a strong positive correlation with the VI both before (p < 0.001) and after (p < 0.001) PEIT. There was no correlation between i-PTH level and the volume of the gland either before (p = 0.697) or after (p...

...Giuseppe Pontoriero; Mario Cozzolino; Francesco Locatelli; Diego Brancaccio Recent observational studies of patients with stage 3–5 chronic kidney disease (CKD) not undergoing dialysis have shown that even slight increases in parathyroid hormone (PTH) levels are associated with an increased...

...) cohorts in 2008. The biochemical variables studied were phosphate, adjusted calcium, calcium phosphate product, parathyroid hormone, bicarbonate, total cholesterol and HbA1c. In addition, longitudinal analyses were performed (2000–2008) to show changes in achievement of clinical performance measures over...

...Shozo Yano; Edward M. Brown; Hirofumi Takase; Akihiko Wada; Keiko Suzuki; Akira Kobayashi; Toshitsugu Sugimoto Background/Aims: Serum parathyroid hormone (PTH) concentration provides a rough index of the severity of secondary hyperparathyroidism (SHPT) due to chronic renal failure. Since serum PTH...

...; it was increased in 22% and decreased in 10.6%. At study end, the mean alfacalcidol dose was 0.32 µg/day. The mean calculated glomerular filtration rate decreased by 2.8 ml/min during the study (p < 0.001). The mean parathyroid hormone (PTH) concentration decreased from 27.5 to 23.1 pmol/l (p < 0.01...

.../Aims: The calcimimetic cinacalcet (Mimpara®/Sensipar®) simultaneously lowers parathyroid hormone (PTH), phosphorus (P) and calcium (Ca) levels in patients with secondary hyperparathyroidism. The OPTIMA study demonstrated that cinacalcet and adjusted doses of vitamin D maximized control...

.... The biochemical variables studied were phosphate, adjusted calcium, parathyroid hormone, bicarbonate and total cholesterol. In addition longitudinal analyses were performed (2000–2007) to show changes in achievement of clinical performance measures over time. Results: Serum phosphate was between 1.1–1.8 mmol/L...

..., we saw recurrent or persistent hyperparathyroidism in 26% and supernumerary glands in 15% of cases. In 7 patients (15%), five or more glands were documented and in another four suspected confirming the clinical relevance of intraoperative parathyroid hormone (PTH) measurement. In our study...